{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:47:32Z","timestamp":1791413252268,"version":"4.3.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s40644-016-0084-2","type":"journal-article","created":{"date-parts":[[2016,8,17]],"date-time":"2016-08-17T10:13:26Z","timestamp":1471428806000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":175,"title":["68Ga-DOTATATE and 18F-FDG PET\/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity"],"prefix":"10.1186","volume":"16","author":[{"given":"Chian A.","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Pattison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Tothill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim J.","family":"Akhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney J.","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Hofman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,17]]},"reference":[{"key":"84_CR1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/jhh.2012.20","volume":"27","author":"D Karasek","year":"2013","unstructured":"Karasek D, Shah U, Frysak Z, Stratakis C, Pacak K. An update on the genetics of pheochromocytoma. J Hum Hypertens. 2013;27:141\u20137.","journal-title":"J Hum Hypertens"},{"key":"84_CR2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2967\/jnumed.111.098152","volume":"53","author":"D Taieb","year":"2012","unstructured":"Taieb D, Neumann H, Rubello D, Al-Nahhas A, Guillet B, Hindie E. Modern nuclear imaging for paragangliomas: beyond SPECT. J Nucl Med. 2012;53:264\u201374.","journal-title":"J Nucl Med"},{"key":"84_CR3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrc3648","volume":"14","author":"PL Dahia","year":"2014","unstructured":"Dahia PL. Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity. Nat Rev Cancer. 2014;14:108\u201319.","journal-title":"Nat Rev Cancer"},{"key":"84_CR4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/path.4503","volume":"236","author":"A Flynn","year":"2015","unstructured":"Flynn A, Benn D, Clifton-Bligh R, Robinson B, Trainer AH, James P, Hogg A, Waldeck K, George J, Li J, et al. The genomic landscape of phaeochromocytoma. J Pathol. 2015;236:78\u201389.","journal-title":"J Pathol"},{"key":"84_CR5","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1038\/ncomms7044","volume":"6","author":"LJ Castro-Vega","year":"2015","unstructured":"Castro-Vega LJ, Letouze E, Burnichon N, Buffet A, Disderot PH, Khalifa E, Loriot C, Elarouci N, Morin A, Menara M, et al. Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas. Nat Commun. 2015;6:6044.","journal-title":"Nat Commun"},{"key":"84_CR6","volume-title":"GeneReviews(R)","author":"S Kirmani","year":"1993","unstructured":"Kirmani S, Young WF. Hereditary Paraganglioma-Pheochromocytoma Syndromes. In: Pagon RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K, editors. GeneReviews(R). Seattle: University of Washington; 1993."},{"key":"84_CR7","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1210\/jc.2015-3889","volume":"101","author":"A Flynn","year":"2016","unstructured":"Flynn A, Dwight T, Harris J, Benn D, Zhou L, Hogg A, Catchpoole D, James P, Duncan EL, Trainer A, et al. Pheo-type: a diagnostic gene-expression assay for the classification of pheochromocytoma and paraganglioma. J Clin Endocrinol Metab. 2016;101:1034\u201343.","journal-title":"J Clin Endocrinol Metab"},{"key":"84_CR8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.beem.2010.04.001","volume":"24","author":"V Kantorovich","year":"2010","unstructured":"Kantorovich V, King KS, Pacak K. SDH-related pheochromocytoma and paraganglioma. Best Pract Res Clin Endocrinol Metab. 2010;24:415\u201324.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"84_CR9","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1210\/jc.2008-2504","volume":"94","author":"N Burnichon","year":"2009","unstructured":"Burnichon N, Rohmer V, Amar L, Herman P, Leboulleux S, Darrouzet V, Niccoli P, Gaillard D, Chabrier G, Chabolle F, et al. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. J Clin Endocrinol Metab. 2009;94:2817\u201327.","journal-title":"J Clin Endocrinol Metab"},{"key":"84_CR10","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s002590100541","volume":"28","author":"JC Reubi","year":"2001","unstructured":"Reubi JC, Waser B, Schaer JC, Laissue JA. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. Eur J Nucl Med. 2001;28:836\u201346.","journal-title":"Eur J Nucl Med"},{"key":"84_CR11","first-page":"1082","volume":"74","author":"JC Reubi","year":"1992","unstructured":"Reubi JC, Waser B, Khosla S, Kvols L, Goellner JR, Krenning E, Lamberts S. In vitro and in vivo detection of somatostatin receptors in pheochromocytomas and paragangliomas. J Clin Endocrinol Metab. 1992;74:1082\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"84_CR12","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2967\/jnumed.108.058701","volume":"50","author":"GA Wiseman","year":"2009","unstructured":"Wiseman GA, Pacak K, O\u2019Dorisio MS, Neumann DR, Waxman AD, Mankoff DA, Heiba SI, Serafini AN, Tumeh SS, Khutoryansky N, Jacobson AF. Usefulness of 123I-MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicenter trial. J Nucl Med. 2009;50:1448\u201354.","journal-title":"J Nucl Med"},{"key":"84_CR13","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/BF00181765","volume":"20","author":"EP Krenning","year":"1993","unstructured":"Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WA, Kooij PP, Oei HY, van Hagen M, Postema PT, de Jong M, Reubi JC, et al. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med. 1993;20:716\u201331.","journal-title":"Eur J Nucl Med"},{"key":"84_CR14","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1200\/JCO.2006.09.6297","volume":"25","author":"HJ Timmers","year":"2007","unstructured":"Timmers HJ, Kozupa A, Chen CC, Carrasquillo JA, Ling A, Eisenhofer G, Adams KT, Solis D, Lenders JW, Pacak K. Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. J Clin Oncol. 2007;25:2262\u20139.","journal-title":"J Clin Oncol"},{"key":"84_CR15","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/jnci\/djs188","volume":"104","author":"HJ Timmers","year":"2012","unstructured":"Timmers HJ, Chen CC, Carrasquillo JA, Whatley M, Ling A, Eisenhofer G, King KS, Rao JU, Wesley RA, Adams KT, Pacak K. Staging and functional characterization of pheochromocytoma and paraganglioma by 18\u00a0F-fluorodeoxyglucose (18\u00a0F-FDG) positron emission tomography. J Natl Cancer Inst. 2012;104:700\u20138.","journal-title":"J Natl Cancer Inst"},{"key":"84_CR16","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s00259-012-2215-8","volume":"39","author":"D Taieb","year":"2012","unstructured":"Taieb D, Timmers HJ, Hindie E, Guillet BA, Neumann HP, Walz MK, Opocher G, de Herder WW, Boedeker CC, de Krijger RR, et al. EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging. 2012;39:1977\u201395.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"84_CR17","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s00259-006-0317-x","volume":"34","author":"P Antunes","year":"2007","unstructured":"Antunes P, Ginj M, Zhang H, Waser B, Baum RP, Reubi JC, Maecke H. Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? Eur J Nucl Med Mol Imaging. 2007;34:982\u201393.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"84_CR18","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.2967\/jnumed.111.091165","volume":"52","author":"TD Poeppel","year":"2011","unstructured":"Poeppel TD, Binse I, Petersenn S, Lahner H, Schott M, Antoch G, Brandau W, Bockisch A, Boy C. 68Ga-DOTATOC versus 68Ga-DOTATATE PET\/CT in functional imaging of neuroendocrine tumors. J Nucl Med. 2011;52:1864\u201370.","journal-title":"J Nucl Med"},{"key":"84_CR19","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00259-010-1720-x","volume":"38","author":"A Kroiss","year":"2011","unstructured":"Kroiss A, Putzer D, Uprimny C, Decristoforo C, Gabriel M, Santner W, Kranewitter C, Warwitz B, Waitz D, Kendler D, Virgolini IJ. Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr 3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine. Eur J Nucl Med Mol Imaging. 2011;38:865\u201373.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"84_CR20","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.2967\/jnumed.111.101675","volume":"53","author":"AR Haug","year":"2012","unstructured":"Haug AR, Cindea-Drimus R, Auernhammer CJ, Reincke M, Wangler B, Uebleis C, Schmidt GP, Goke B, Bartenstein P, Hacker M. The role of 68Ga-DOTATATE PET\/CT in suspected neuroendocrine tumors. J Nucl Med. 2012;53:1686\u201392.","journal-title":"J Nucl Med"},{"key":"84_CR21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1754-9485.2011.02327.x","volume":"56","author":"MS Hofman","year":"2012","unstructured":"Hofman MS, Kong G, Neels OC, Eu P, Hong E, Hicks RJ. High management impact of Ga-68 DOTATATE (GaTate) PET\/CT for imaging neuroendocrine and other somatostatin expressing tumours. J Med Imaging Radiat Oncol. 2012;56:40\u20137.","journal-title":"J Med Imaging Radiat Oncol"},{"key":"84_CR22","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nrendo.2009.105","volume":"5","author":"M Essen van","year":"2009","unstructured":"van Essen M, Krenning EP, Kam BL, de Jong M, Valkema R, Kwekkeboom DJ. Peptide-receptor radionuclide therapy for endocrine tumors. Nat Rev Endocrinol. 2009;5:382\u201393.","journal-title":"Nat Rev Endocrinol"},{"key":"84_CR23","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1055\/s-0032-1311637","volume":"44","author":"S Zovato","year":"2012","unstructured":"Zovato S, Kumanova A, Dematte S, Sansovini M, Bodei L, Di Sarra D, Casagranda E, Severi S, Ambrosetti A, Schiavi F, et al. Peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE in individuals with neck or mediastinal paraganglioma (PGL). Horm Metab Res. 2012;44:411\u20134.","journal-title":"Horm Metab Res"},{"key":"84_CR24","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1210\/edrv-12-4-450","volume":"12","author":"SW Lamberts","year":"1991","unstructured":"Lamberts SW, Krenning EP, Reubi JC. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev. 1991;12:450\u201382.","journal-title":"Endocr Rev"},{"key":"84_CR25","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1158\/1078-0432.CCR-14-2751","volume":"21","author":"I Janssen","year":"2015","unstructured":"Janssen I, Blanchet EM, Adams K, Chen CC, Millo CM, Herscovitch P, Taieb D, Kebebew E, Lehnert H, Fojo AT, Pacak K. Superiority of [68Ga]-DOTATATE PET\/CT to other functional imaging modalities in the localization of SDHB-associated metastatic Pheochromocytoma and paraganglioma. Clin Cancer Res. 2015;21:3888\u201395.","journal-title":"Clin Cancer Res"},{"key":"84_CR26","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1007\/s00259-015-3268-2","volume":"43","author":"A Archier","year":"2015","unstructured":"Archier A, Varoquaux A, Garrigue P, Montava M, Guerin C, Gabriel S, Beschmout E, Morange I, Fakhry N, Castinetti F, et al. Prospective comparison of Ga-DOTATATE and F-FDOPA PET\/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases. Eur J Nucl Med Mol Imaging. 2015;43:1248\u201357.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"84_CR27","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2967\/jnumed.108.060731","volume":"50","author":"D Taieb","year":"2009","unstructured":"Taieb D, Sebag F, Barlier A, Tessonnier L, Palazzo FF, Morange I, Niccoli-Sire P, Fakhry N, De Micco C, Cammilleri S, et al. 18\u00a0F-FDG avidity of pheochromocytomas and paragangliomas: a new molecular imaging signature? J Nucl Med. 2009;50:711\u20137.","journal-title":"J Nucl Med"},{"key":"84_CR28","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/jc.2005-1862","volume":"91","author":"DE Benn","year":"2006","unstructured":"Benn DE, Gimenez-Roqueplo AP, Reilly JR, Bertherat J, Burgess J, Byth K, Croxson M, Dahia PL, Elston M, Gimm O, et al. Clinical presentation and penetrance of pheochromocytoma\/paraganglioma syndromes. J Clin Endocrinol Metab. 2006;91:827\u201336.","journal-title":"J Clin Endocrinol Metab"},{"key":"84_CR29","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.292.8.943","volume":"292","author":"HP Neumann","year":"2004","unstructured":"Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, Buchta M, Franke G, Klisch J, Bley TA, et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA. 2004;292:943\u201351.","journal-title":"JAMA"},{"key":"84_CR30","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1210\/jc.2006-2315","volume":"92","author":"HJ Timmers","year":"2007","unstructured":"Timmers HJ, Kozupa A, Eisenhofer G, Raygada M, Adams KT, Solis D, Lenders JW, Pacak K. Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas. J Clin Endocrinol Metab. 2007;92:779\u201386.","journal-title":"J Clin Endocrinol Metab"},{"key":"84_CR31","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1007\/s00259-012-2119-7","volume":"39","author":"JB Maurice","year":"2012","unstructured":"Maurice JB, Troke R, Win Z, Ramachandran R, Al-Nahhas A, Naji M, Dhillo W, Meeran K, Goldstone AP, Martin NM, et al. A comparison of the performance of (6)(8)Ga-DOTATATE PET\/CT and (1)(2)(3)I-MIBG SPECT in the diagnosis and follow-up of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging. 2012;39:1266\u201370.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"84_CR32","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s11307-010-0396-8","volume":"13","author":"M Naji","year":"2011","unstructured":"Naji M, Zhao C, Welsh SJ, Meades R, Win Z, Ferrarese A, Tan T, Rubello D, Al-Nahhas A. 68Ga-DOTA-TATE PET vs. 123I-MIBG in identifying malignant neural crest tumours. Mol Imaging Biol. 2011;13:769\u201375.","journal-title":"Mol Imaging Biol"},{"key":"84_CR33","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1158\/1078-0432.CCR-15-1073","volume":"21","author":"MS Hofman","year":"2015","unstructured":"Hofman MS, Hicks RJ. Moving beyond \u201cLumpology\u201d: PET\/CT imaging of Pheochromocytoma and paraganglioma. Clin Cancer Res. 2015;21:3815\u20137.","journal-title":"Clin Cancer Res"},{"key":"84_CR34","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/cen.12566","volume":"81","author":"P Santhanam","year":"2014","unstructured":"Santhanam P, Taieb D. Role of (18) F-FDOPA PET\/CT imaging in endocrinology. Clin Endocrinol (Oxf). 2014;81:789\u201398.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"84_CR35","first-page":"58","volume":"1","author":"EM Blanchet","year":"2011","unstructured":"Blanchet EM, Martucci V, Pacak K. Pheochromocytoma and paraganglioma: current functional and future molecular imaging. Front Oncol. 2011;1:58.","journal-title":"Front Oncol"},{"key":"84_CR36","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1210\/jc.2009-1248","volume":"94","author":"HJ Timmers","year":"2009","unstructured":"Timmers HJ, Chen CC, Carrasquillo JA, Whatley M, Ling A, Havekes B, Eisenhofer G, Martiniova L, Adams KT, Pacak K. Comparison of 18\u00a0F-fluoro-L-DOPA, 18\u00a0F-fluoro-deoxyglucose, and 18\u00a0F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. J Clin Endocrinol Metab. 2009;94:4757\u201367.","journal-title":"J Clin Endocrinol Metab"},{"key":"84_CR37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s13139-014-0276-2","volume":"48","author":"J Park","year":"2014","unstructured":"Park J, Byun BH, Jung CW, Moon H, Chang KJ, Lim I, Kim BI, Choi CW, Lim SM. Perirenal (18)F-FDG uptake in a patient with a Pheochromocytoma. Nucl Med Mol Imaging. 2014;48:233\u20136.","journal-title":"Nucl Med Mol Imaging"},{"key":"84_CR38","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00259-007-0538-7","volume":"35","author":"LY Yamaga","year":"2008","unstructured":"Yamaga LY, Thom AF, Wagner J, Baroni RH, Hidal JT, Funari MG. The effect of catecholamines on the glucose uptake in brown adipose tissue demonstrated by (18)F-FDG PET\/CT in a patient with adrenal pheochromocytoma. Eur J Nucl Med Mol Imaging. 2008;35:446\u20137.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"84_CR39","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1259\/bjr\/24661539","volume":"82","author":"A Agrawal","year":"2009","unstructured":"Agrawal A, Nair N, Baghel NS. A novel approach for reduction of brown fat uptake on FDG PET. Br J Radiol. 2009;82:626\u201331.","journal-title":"Br J Radiol"},{"key":"84_CR40","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/1935b388-2831-4fb1-b8f2-914ab91c1ddc","volume":"6","author":"Q Wang","year":"2011","unstructured":"Wang Q, Zhang M, Ning G, Gu W, Su T, Xu M, Li B, Wang W. Brown adipose tissue in humans is activated by elevated plasma catecholamines levels and is inversely related to central obesity. PLoS One. 2011;6, e21006.","journal-title":"PLoS One"},{"key":"84_CR41","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/SLA.0b013e3181fd37e8","volume":"252","author":"A Frilling","year":"2010","unstructured":"Frilling A, Sotiropoulos GC, Radtke A, Malago M, Bockisch A, Kuehl H, Li J, Broelsch CE. The impact of 68Ga-DOTATOC positron emission tomography\/computed tomography on the multimodal management of patients with neuroendocrine tumors. Ann Surg. 2010;252:850\u20136.","journal-title":"Ann Surg"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-016-0084-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T16:52:50Z","timestamp":1498323170000},"score":1,"resource":{"primary":{"URL":"http:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-016-0084-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,17]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["84"],"URL":"https:\/\/doi.org\/10.1186\/s40644-016-0084-2","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,17]]},"article-number":"22"}}